Breakthrough for Gene Therapy: FDA Designates Viral Vector in Sarepta’s SRP-9003 for Limb Girdle Muscular Dystrophy Treatment
The U.S. FDA has officially awarded Platform Technology Designation to the viral vector used in Sarepta Therapeutics' groundbreaking gene therapy, ...
Read moreDetails
